Carregant...
The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
Biosimilar medicines expand the biotherapeutic market and improve patient access. This work looked into the landscape of the European and US biosimilar products, their regulatory authorization, market availability, and clinical evaluation undergone prior to the regulatory approval. European Medicine...
Guardat en:
| Publicat a: | Pharmaceutics |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7824407/ https://ncbi.nlm.nih.gov/pubmed/33396369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13010048 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|